Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

Clinical implications of Ezrin and CD44 coexpression in breast cancer

By    

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1899-1905

Spandidos Publications

Access to resources Recommend Favorite

Vimentin DNA methylation predicts survival in breast cancer

By Ulirsch Jacob  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 383-396

Springer Publishing Company

Access to resources Recommend Favorite

Breast Cancer Outcomes and Micrometastatic Disease

By Giuliano Armando  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1258-1258

Springer Publishing Company

Access to resources Recommend Favorite

Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer

By Li Shunrong   Liu Jieqiong   Yang Yaping   Zeng Yunjie   Deng Heran   Jia Haixia   Li Qian   Feng Huiyi   Li Yangyang   Song Erwei   Liu Qiang   Su Fengxi  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 599-605

Springer Publishing Company

Access to resources Recommend Favorite